Navigation Links
PTC Therapeutics' President and CEO Elected AAAS Fellow
Date:1/19/2011

SOUTH PLAINFIELD, N.J., Jan. 19, 2011 /PRNewswire/ -- Stuart W. Peltz, Ph.D., President and CEO of PTC Therapeutics, Inc. (PTC), has been elected a Fellow of the American Association for the Advancement of Science (AAAS), the world's largest general scientific society and publisher of the journal Science.  AAAS Fellows are chosen by their peers and recognized for their scientifically or socially distinguished efforts to advance science or its applications.

(Logo: http://photos.prnewswire.com/prnh/20010919/PTCLOGO)

As part of the Biological Science Section, Dr. Peltz is recognized for his "distinguished contributions in the area of genetics and RNA biochemistry, specifically mRNA stability and decay."  Dr. Peltz co-founded PTC Therapeutics in 1998 with the goal of discovering, developing and commercializing innovative therapies in areas of high unmet medical need based on RNA biochemistry and post-transcriptional control mechanisms.  While a total of 503 Fellows were recognized for 2010, Dr. Peltz is one of only ten Fellows elected who are currently in industry.  

"On behalf of the Board and the broader PTC community, we all congratulate Stuart for the AAAS Council's recognition for the excellence and value of his work in genetics and RNA biochemistry.  We all agree this is well deserved," said Michael Schmertzler, Chairman of the Board of Directors of PTC Therapeutics.

The tradition of AAAS Fellows began in 1874.  Currently, members can be considered for the rank of Fellow if nominated by the steering groups of the Association's 24 sections, or by any three Fellows who are current AAAS members, or by the AAAS chief executive officer.  Each steering group then reviews the nominations of individuals within its respective section and forwards a final list to the AAAS Council.  The AAAS Council, the association's policymaking body, votes on the final list.

"This is a great honor, for which a very large portion of the credit goes to my students, collaborators, colleagues and employees at PTC," said Dr. Stuart Peltz, President and CEO.  "We are committed to applying innovative science to develop therapies for diseases that currently have little or no treatment options."  

About PTC Therapeutics, Inc.

PTC is a biopharmaceutical company focused on the discovery, development and commercialization of orally administered small-molecule drugs that target post-transcriptional control processes.  Post-transcriptional control processes regulate the rate and timing of protein production and are of central importance to proper cellular function.  PTC's internally discovered pipeline addresses multiple therapeutic areas, including rare genetic disorders, oncology and infectious diseases.  PTC has developed proprietary technologies that it applies in its drug discovery activities and is the basis for collaborations with leading biopharmaceutical companies.  For more information, visit the company's web site at www.ptcbio.com.


'/>"/>
SOURCE PTC Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Resolvyx Pharmaceuticals and Celtic Therapeutics Enter Final Agreement in Ophthalmology
2. ADVENTRX Announces Signing of Term Sheet for Acquisition of Poloxamer-Based Therapeutics
3. Echo Therapeutics to Present at the OneMedForum 2011 Conference
4. Esperion Therapeutics Initiates Phase 2 Clinical Study for ETC-1002
5. Altheus Therapeutics Completes Phase I Clinical Study of Zoenasa™ in Ulcerative Colitis
6. Echo Therapeutics Receives Funding and Commitment of Approximately $5.5 Million
7. Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.
8. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 29th Annual J.P. Morgan Healthcare Conference in San Francisco, CA
9. Amicus Therapeutics to Present at the 29th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2011
10. Halozyme Therapeutics to Present at J.P. Morgan Healthcare Conference on January 12
11. Karyopharm Therapeutics Inc. Appoints Michael Kauffman, MD, PhD, as Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... Analysis 2016 - Forecast to 2022" report to their ... contains up to date financial data derived from varied research ... trends with potential impact on the market during the next ... which comprises of sub markets, regional and country level analysis. ...
(Date:6/23/2016)... MOUNTAIN VIEW, Calif. , June 23, 2016 ... 9:00 a.m. CST on Thursday, July 7, 2016 , , ... kayla.belcher@frost.com ) , , , , EXPERT PANELISTS:  ... Sciences, Nitin Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, ... The global pharmaceutical industry is witnessing ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 26, 2016 , ... PawPaws brand pet supplements owned by Whole ... enhance the health of felines. The formula is all-natural and is made from Chinese ... PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
Breaking Medicine News(10 mins):